✦ LIBER ✦

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine

✍ Scribed by SR Walsh, MS Seaman, JA Johnson, RP Tucker, KH Krause, M Weijtens, MG Pau…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-in-Human Evaluation of the Safety

✍ Baden, L. R.; Walsh, S. R.; Seaman, M. S.; Tucker, R. P.; Krause, K. H.; Patel, 📂 Article 📅 2012 🏛 University of Chicago Press 🌐 English ⚖ 767 KB

OA05-06 LB. First-in-human Phase 1 safet

✍ LR Baden, R Dolin, KL O'Brien, P Abbink, A La Porte, MS Seaman, E Choi… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 63 KB

Safety and immunogenicity of the recombi

✍ Grode, Leander; Ganoza, Christian A.; Brohm, Christiane; Weiner, January; Eisele 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 730 KB

Immunogenicity and Safety of the Quadriv

✍ Kojic, E. M.; Kang, M.; Cespedes, M. S.; Umbleja, T.; Godfrey, C.; Allen, R. T.; 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 426 KB

First-in-human phase I clinical trial of

✍ JD Fuchs, I Frank, N Kochar, M Elizaga, M Allen, D Carter, N Frahm… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 64 KB

Phase 1 first-in-human studies of the re

✍ Scott A. Halperin; Joanne M. Langley; Bruce Smith; Peter Wunderli; Lisa Kaufman; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 140 KB